Bayer Collaborates with GeneData, Becomes First Customer for New System | GenomeWeb

BASEL, Switzerland--GeneData, a privately-held bioinformatics company based here, has announced the release of GD Phylosopher, a functional genomics-based target identification system that it developed with the help of Bayer's pharmaceutical anti-infectives research unit, which is also the first user of the product. Applied to microbial genomes, the system identifies novel targets for next-generation antibiotics. GD Phylosopher is an automated, high-throughput system for gene function prediction and elucidation of essential biochemical pathways from complete genomes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.